Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2019

01-10-2019 | Research Article

Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method

Authors: Qiaozhi Hu, Zhou Qin, Mei Zhan, Bin Wu, Zhaoyan Chen, Ting Xu

Published in: International Journal of Clinical Pharmacy | Issue 5/2019

Login to get access

Abstract

Background The global trigger tool is a method of retrospective medical record review that identifies possible harm in hospitalized patients using “triggers”. Elderly patients with multiple co-morbid illnesses are especially vulnerable to adverse drug events (ADEs) that have high prevalence rates. Objective The purpose of this study was to develop an appropriate trigger tool to detect ADEs in Chinese geriatric inpatients by combining a literature review with the Delphi method. Setting Chinese geriatric inpatients. Methods Two steps were used to develop the trigger tool. First, we conducted a comprehensive literature review for existing ADE triggers (adult or elderly) to form the initial triggers for the Delphi process. Second, a group of clinical experts, including physicians, clinical pharmacists and nurses, was established to score candidate triggers for utility according to the usefulness and feasibility of implementing triggers in clinical practice. Main outcome measures The frequency of the full mark, arithmetic mean and coefficient of variation of each trigger. Results An initial set of 51 triggers was selected by literature review for evaluation. The group of experts was composed of 18 clinical experts: 13 physicians, 4 clinical pharmacists, and 1 nurse. Based on the two-phase Delphi process, 42 triggers in five categories (laboratory index, plasma concentration, antidotes, clinical symptoms and intervention) were retained. Conclusion The 42-trigger tool was developed to identify ADEs in Chinese geriatric inpatients. A pilot study that tests the list of triggers to identify ADEs in Chinese geriatric inpatients is the next step for establishing a specific trigger tool for Chinese geriatric inpatients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10(4):199–205.PubMedCrossRef Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10(4):199–205.PubMedCrossRef
2.
go back to reference Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000. Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.
3.
go back to reference Piquette-Miller M, Grant DM. The art and science of personalized medicine. Clin Pharmacol Ther. 2007;81(3):311–5.PubMedCrossRef Piquette-Miller M, Grant DM. The art and science of personalized medicine. Clin Pharmacol Ther. 2007;81(3):311–5.PubMedCrossRef
4.
go back to reference Lunshof JE, Pirmohamed M, Gurwitz D. Personalized medicine: decades away? Pharmacogenomics. 2006;7(2):237–41.PubMedCrossRef Lunshof JE, Pirmohamed M, Gurwitz D. Personalized medicine: decades away? Pharmacogenomics. 2006;7(2):237–41.PubMedCrossRef
5.
go back to reference Hakkarainen KM, Hedna K, Petzold M, Hägg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions—a meta-analysis. PLoS ONE. 2012;7:e33236.PubMedPubMedCentralCrossRef Hakkarainen KM, Hedna K, Petzold M, Hägg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions—a meta-analysis. PLoS ONE. 2012;7:e33236.PubMedPubMedCentralCrossRef
7.
go back to reference Naessens JM, Campbell CR, Huddleston JM, Berg BP, Lefante JJ, Williams AR, Culbertson RA. Comparison of hospital adverse events identified by three widely used detection methods. Int J Qual Health Care. 2009;21(4):301–7.PubMedCrossRef Naessens JM, Campbell CR, Huddleston JM, Berg BP, Lefante JJ, Williams AR, Culbertson RA. Comparison of hospital adverse events identified by three widely used detection methods. Int J Qual Health Care. 2009;21(4):301–7.PubMedCrossRef
8.
go back to reference Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. ‘Global trigger tool’ shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff. 2011;30(4):581–9.CrossRef Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. ‘Global trigger tool’ shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff. 2011;30(4):581–9.CrossRef
10.
go back to reference Landrigan CP, Parry GJ. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med. 2010;364(7):2124–34.CrossRef Landrigan CP, Parry GJ. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med. 2010;364(7):2124–34.CrossRef
11.
go back to reference Rutberg H, Borgstedt Risberg M, Sjödahl R, Nordqvist P, Valter L, Nilsson L. Characterisations of adverse events detected in a university hospital: a 4-year study using the global trigger tool method. BMJ Open. 2014;4(5):e004879.PubMedPubMedCentralCrossRef Rutberg H, Borgstedt Risberg M, Sjödahl R, Nordqvist P, Valter L, Nilsson L. Characterisations of adverse events detected in a university hospital: a 4-year study using the global trigger tool method. BMJ Open. 2014;4(5):e004879.PubMedPubMedCentralCrossRef
12.
go back to reference Classen DC, Lloyd RC, Provost L, Griffin FA, Resar R. Development and evaluation of the institute for healthcare improvement global trigger tool. J Patient Saf. 2008;4(3):169–77.CrossRef Classen DC, Lloyd RC, Provost L, Griffin FA, Resar R. Development and evaluation of the institute for healthcare improvement global trigger tool. J Patient Saf. 2008;4(3):169–77.CrossRef
13.
go back to reference Handler SM, Hanlon JT. Detecting adverse drug events using a nursing home specific trigger tool. Ann Longterm Care. 2010;18(5):17–22.PubMedPubMedCentral Handler SM, Hanlon JT. Detecting adverse drug events using a nursing home specific trigger tool. Ann Longterm Care. 2010;18(5):17–22.PubMedPubMedCentral
14.
go back to reference Chapman SM, Fitzsimons J, Davey N, Lachman P. Prevalence and severity of patient harm in a sample of UK-hospitalised children detected by the paediatric trigger tool. BMJ Open. 2014;4(7):e005066.PubMedPubMedCentralCrossRef Chapman SM, Fitzsimons J, Davey N, Lachman P. Prevalence and severity of patient harm in a sample of UK-hospitalised children detected by the paediatric trigger tool. BMJ Open. 2014;4(7):e005066.PubMedPubMedCentralCrossRef
15.
go back to reference Hibbert PD, Hallahan AR, Muething SE, Lachman P, Hooper TD, Wiles LK, et al. CareTrack kids-part 3. Adverse events in children’s healthcare in Australia: study protocol for a retrospective medical record review. BMJ Open. 2015;5(4):e007750.PubMedPubMedCentralCrossRef Hibbert PD, Hallahan AR, Muething SE, Lachman P, Hooper TD, Wiles LK, et al. CareTrack kids-part 3. Adverse events in children’s healthcare in Australia: study protocol for a retrospective medical record review. BMJ Open. 2015;5(4):e007750.PubMedPubMedCentralCrossRef
16.
go back to reference Hwang JI, Chin HJ. Characteristics associated with the occurrence of adverse events: a retrospective medical record review using the global trigger tool in a fully digitalized tertiary teaching hospital in Korea. J Eval Clin Pract. 2014;20(1):27–35.PubMedCrossRef Hwang JI, Chin HJ. Characteristics associated with the occurrence of adverse events: a retrospective medical record review using the global trigger tool in a fully digitalized tertiary teaching hospital in Korea. J Eval Clin Pract. 2014;20(1):27–35.PubMedCrossRef
17.
go back to reference Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital. Ann Pharmacother. 2013;47(11):1414–9.PubMedCrossRef Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital. Ann Pharmacother. 2013;47(11):1414–9.PubMedCrossRef
18.
go back to reference Resar RK, Rozich JD. Methodology and rationale for the measurement of harm with trigger tools. Methodology and rationale for the measurement of harm with trigger tools. 2003;12(Suppl 2):ii39–45. Resar RK, Rozich JD. Methodology and rationale for the measurement of harm with trigger tools. Methodology and rationale for the measurement of harm with trigger tools. 2003;12(Suppl 2):ii39–45.
19.
go back to reference Klopotowska JE, Wierenga PC, Stuijt CC, Arisz L, Dijkgraaf MG, Kuks PF, et al. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy. PLoS ONE. 2013;8(8):e71045.PubMedPubMedCentralCrossRef Klopotowska JE, Wierenga PC, Stuijt CC, Arisz L, Dijkgraaf MG, Kuks PF, et al. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy. PLoS ONE. 2013;8(8):e71045.PubMedPubMedCentralCrossRef
20.
go back to reference Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.PubMedCrossRef Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.PubMedCrossRef
21.
go back to reference Handler SM, Wright RM. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother. 2006;4(2):264–72.PubMedCrossRef Handler SM, Wright RM. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother. 2006;4(2):264–72.PubMedCrossRef
22.
go back to reference McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163–84.PubMedCrossRef McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163–84.PubMedCrossRef
24.
26.
go back to reference Wang C, Si Q. A study of data statistical processing method of Delphi method and its application. J Inner Mong Univ Finance Econ. 2011;9(4):92–6. Wang C, Si Q. A study of data statistical processing method of Delphi method and its application. J Inner Mong Univ Finance Econ. 2011;9(4):92–6.
27.
go back to reference Tan H, Ping W, Yang T, Li S, Liu A, Zhou J, et al. The synthetic evaluation model for analysis of flooding hazards. Eur J Public Health. 2006;17(2):206–10.PubMedCrossRef Tan H, Ping W, Yang T, Li S, Liu A, Zhou J, et al. The synthetic evaluation model for analysis of flooding hazards. Eur J Public Health. 2006;17(2):206–10.PubMedCrossRef
28.
go back to reference Cafiso S, Di Graziano A, Pappalardo G. Using the Delphi method to evaluate opinions of public transport managers on bus safety. Saf Sci. 2013;57:254–63.CrossRef Cafiso S, Di Graziano A, Pappalardo G. Using the Delphi method to evaluate opinions of public transport managers on bus safety. Saf Sci. 2013;57:254–63.CrossRef
29.
go back to reference Brenner S, Detz A, Lopez A, Horton C, Sarkar U. Signal and noise: applying a laboratory trigger tool to identify adverse drug events among primary care patients. BMJ Qual Saf. 2012;21(8):670–5.PubMedPubMedCentralCrossRef Brenner S, Detz A, Lopez A, Horton C, Sarkar U. Signal and noise: applying a laboratory trigger tool to identify adverse drug events among primary care patients. BMJ Qual Saf. 2012;21(8):670–5.PubMedPubMedCentralCrossRef
30.
go back to reference Hébert G, Netzer F. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool. Eur J Cancer. 2015;51(3):427–35.PubMedCrossRef Hébert G, Netzer F. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool. Eur J Cancer. 2015;51(3):427–35.PubMedCrossRef
31.
go back to reference Rozich JD, Haraden CR. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194–200.PubMedPubMedCentralCrossRef Rozich JD, Haraden CR. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194–200.PubMedPubMedCentralCrossRef
32.
go back to reference Marcum ZA, Arbogast KL, Behrens MC, Logsdon MW, Francis SD, Jeffery SM, et al. Utility of an adverse drug event trigger tool in veterans affairs nursing facilities. Consult Pharm. 2013;28(2):99–109.PubMedPubMedCentralCrossRef Marcum ZA, Arbogast KL, Behrens MC, Logsdon MW, Francis SD, Jeffery SM, et al. Utility of an adverse drug event trigger tool in veterans affairs nursing facilities. Consult Pharm. 2013;28(2):99–109.PubMedPubMedCentralCrossRef
33.
go back to reference Franklin BD, Birch S, Schachter M, Barber N. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study. Int J Pharm Pract. 2010;18(5):305–11.PubMedCrossRef Franklin BD, Birch S, Schachter M, Barber N. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study. Int J Pharm Pract. 2010;18(5):305–11.PubMedCrossRef
34.
go back to reference Lau I, Kirkwood A. Measuring adverse drug events on hospital medicine units with the institute for healthcare improvement trigger tool: a chart review. Can J Hosp Pharm. 2014;67(6):423–8.PubMedPubMedCentral Lau I, Kirkwood A. Measuring adverse drug events on hospital medicine units with the institute for healthcare improvement trigger tool: a chart review. Can J Hosp Pharm. 2014;67(6):423–8.PubMedPubMedCentral
35.
go back to reference Seynaeve S, Verbrugghe W. Adverse drug events in intensive care units: a cross-sectional study of prevalence and risk factors. Am J Crit Care. 2011;20(6):e131–40.PubMedCrossRef Seynaeve S, Verbrugghe W. Adverse drug events in intensive care units: a cross-sectional study of prevalence and risk factors. Am J Crit Care. 2011;20(6):e131–40.PubMedCrossRef
37.
go back to reference Falconer N, Nand S. Development of an electronic patient prioritization tool for clinical pharmacist interventions. Am J Health Syst Pharm. 2014;71(4):311–20.PubMedCrossRef Falconer N, Nand S. Development of an electronic patient prioritization tool for clinical pharmacist interventions. Am J Health Syst Pharm. 2014;71(4):311–20.PubMedCrossRef
38.
go back to reference Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ, et al. Practice parameters committee of the American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950–66.PubMedCrossRef Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ, et al. Practice parameters committee of the American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950–66.PubMedCrossRef
39.
go back to reference Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266(20):2847–51.PubMedCrossRef Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266(20):2847–51.PubMedCrossRef
40.
go back to reference Keith MR, Bellanger-McCleery RA, Fuchs JE Jr. Multidisciplinary program for detecting and evaluating adverse drug reactions. Am J Hosp Pharm. 1989;46:1809–12.PubMed Keith MR, Bellanger-McCleery RA, Fuchs JE Jr. Multidisciplinary program for detecting and evaluating adverse drug reactions. Am J Hosp Pharm. 1989;46:1809–12.PubMed
41.
go back to reference Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS ONE. 2011;6(6):e20476.PubMedPubMedCentralCrossRef Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS ONE. 2011;6(6):e20476.PubMedPubMedCentralCrossRef
42.
go back to reference Kaafarani HM, Rosen AK, Nebeker JR, Shimada S, Mull HJ, Rivard PE, et al. Development of trigger tools for surveillance of adverse events in ambulatory surgery. Qual Saf Health Care. 2010;19(5):425–9.PubMed Kaafarani HM, Rosen AK, Nebeker JR, Shimada S, Mull HJ, Rivard PE, et al. Development of trigger tools for surveillance of adverse events in ambulatory surgery. Qual Saf Health Care. 2010;19(5):425–9.PubMed
43.
go back to reference Van Teijlingen E, Pitchforth E, Bishop C, Russell E. Delphi method and nominal group technique in family planning and reproductive health research. J Fam Plan Reprod Health Care. 2006;32(4):249–52.CrossRef Van Teijlingen E, Pitchforth E, Bishop C, Russell E. Delphi method and nominal group technique in family planning and reproductive health research. J Fam Plan Reprod Health Care. 2006;32(4):249–52.CrossRef
44.
go back to reference Adaway JE, Keevil BG. Therapeutic drug monitoring and LC–MS/MS. J Chromatogr B. 2012;883–884(4):33–49.CrossRef Adaway JE, Keevil BG. Therapeutic drug monitoring and LC–MS/MS. J Chromatogr B. 2012;883–884(4):33–49.CrossRef
45.
46.
47.
go back to reference Stuck AE, Kharicha K, Dapp U, Anders J, von Renteln-Kruse W, Meier-Baumgartner HP, et al. The PRO-AGE study: an international randomized controlled study of health risk appraisal for older persons based in general practice. BMC Med Res Methodol. 2007;7:2.PubMedPubMedCentralCrossRef Stuck AE, Kharicha K, Dapp U, Anders J, von Renteln-Kruse W, Meier-Baumgartner HP, et al. The PRO-AGE study: an international randomized controlled study of health risk appraisal for older persons based in general practice. BMC Med Res Methodol. 2007;7:2.PubMedPubMedCentralCrossRef
48.
go back to reference Guerra IC, Ramoscerqueira AT. Risk of repeated hospitalizations in elderly users of an academic health center. Cad Saude Publica. 2007;23(3):585–92.PubMedCrossRef Guerra IC, Ramoscerqueira AT. Risk of repeated hospitalizations in elderly users of an academic health center. Cad Saude Publica. 2007;23(3):585–92.PubMedCrossRef
49.
go back to reference Kennedy BS, Kasl SV, Vaccarino V. Repeated hospitalizations and self-rated health among the elderly: a multivariate failure time analysis. Am J Epidemiol. 2001;153(3):232–41.PubMedCrossRef Kennedy BS, Kasl SV, Vaccarino V. Repeated hospitalizations and self-rated health among the elderly: a multivariate failure time analysis. Am J Epidemiol. 2001;153(3):232–41.PubMedCrossRef
50.
go back to reference Hu Q, Wu B, Zhan M, Jia W, Huang Y, Xu T. Adverse events identified by the global trigger tool at a university hospital: a retrospective medical record review. J Evid Based Med. 2019;12(2):91–7.PubMedCrossRef Hu Q, Wu B, Zhan M, Jia W, Huang Y, Xu T. Adverse events identified by the global trigger tool at a university hospital: a retrospective medical record review. J Evid Based Med. 2019;12(2):91–7.PubMedCrossRef
Metadata
Title
Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method
Authors
Qiaozhi Hu
Zhou Qin
Mei Zhan
Bin Wu
Zhaoyan Chen
Ting Xu
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00871-x

Other articles of this Issue 5/2019

International Journal of Clinical Pharmacy 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.